P-GLYCOPROTEIN AND DRUG-RESISTANCE IN ACUTE LEUKEMIAS AND IN THE BLASTIC CRISIS OF CHRONIC MYELOID-LEUKEMIA

被引：0
|
作者：
CARULLI, G
PETRINI, M
MARINI, A
VAGLINI, F
CARACCIOLO, F
GRASSI, B
机构：
[1] UNIV PISA,MED CLIN 1,UNITA EMATOL,I-56100 PISA,ITALY
[2] UNIV PISA,IST FARMACOL,I-56100 PISA,ITALY
来源：
HAEMATOLOGICA | 1990年 / 75卷 / 06期
关键词：
CHEMORESISTANCE; LEUKEMIA; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN; P-170;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The aim of this work is to evaluate the relationship between P-glycoprotein expression in circulating blasts and clinical response in patients suffering from acute lymphoblastic leukemia, acute non-lymphoblastic leukemia, and chronic myeloid leukemia in either lymphoid or myeloid blastic crisis. The results obtained show that: a) patients whose blasts express P-glycoprotein are resistant towards protocols including Doxorubicin, Daunorubicin, Etoposide, Mithramycin, Vincristine; b) P-glycoprotein can be expressed constitutively in some cases; c) P-glycoprotein does not appear to be the only mechanism responsible for resistance towards anthracyclines and Etoposide.
引用
收藏
页码：516 / 521
页数：6
相关论文
共 50 条
  • [21] Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias
    Benderra, Z
    Faussat, AM
    Sayada, L
    Perrot, JY
    Chaoui, D
    Marie, JP
    Legrand, O
    CLINICAL CANCER RESEARCH, 2004, 10 (23) : 7896 - 7902
  • [22] THE TERMINAL DESOXYNUCLEOTIDYLTRANSFERASE (TDT) - ITS SIGNIFICANCE FOR THE CLASSIFICATION OF ACUTE-LEUKEMIA AND THE BLASTIC CRISIS OF CHRONIC MYELOID-LEUKEMIA
    SCHWARZMEIER, JD
    PAIETTA, E
    ACTA MEDICA AUSTRIACA, 1982, 9 (5-6) : 220 - 220
  • [23] THE APPLICATION OF THE MTT ASSAY TO STUDY DRUG-RESISTANCE AND DRUG-COMBINATIONS IN ACUTE MYELOID-LEUKEMIA
    SARGENT, JM
    TAYLOR, CG
    ELGIE, AW
    WILSON, KK
    BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 512 - 512
  • [24] USE OF THE MTT ASSAY TO ASSESS DRUG-RESISTANCE PATTERNS IN ACUTE MYELOID-LEUKEMIA (AML)
    PHILLIPS, JK
    BRITISH JOURNAL OF CANCER, 1990, 61 (06) : 950 - 951
  • [25] IMMUNOPHENOTYPE OF CHRONIC MYELOID-LEUKEMIA BLASTIC PHASE
    LOPEZKARPOVITCH, X
    CARDENAS, MR
    PIEDRAS, J
    BLOOD, 1994, 84 (10) : A633 - A633
  • [26] LYMPHOID BLASTIC TRANSFORMATION IN CHRONIC MYELOID-LEUKEMIA
    VILLEGAS, A
    GONZALEZ, FA
    LOPEZ, M
    ARMADA, B
    JORDA, J
    ALARCON, C
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (01) : 58 - 59
  • [27] DIFFERENT KINETIC PATTERN OF CHRONIC MYELOID-LEUKEMIA - LYMPHOBLASTIC AND MYELOBLASTIC BLASTIC CRISIS
    PIACIBELLO, W
    AGLIETTA, M
    GAVOSTO, F
    TUMORI, 1980, 66 (03) : 295 - 303
  • [28] T(15 - 17) IN A PROMYELOCYTIC FORM OF CHRONIC MYELOID-LEUKEMIA BLASTIC CRISIS
    BERGER, R
    BERNHEIM, A
    DANIEL, MT
    FLANDRIN, G
    CANCER GENETICS AND CYTOGENETICS, 1983, 8 (02) : 149 - 152
  • [29] PREVENTION OF BLASTIC CRISIS IN PH1-POSITIVE CHRONIC MYELOID-LEUKEMIA
    SHARP, JC
    RECENT RESULTS IN CANCER RESEARCH, 1982, 80 : 78 - 82
  • [30] SPECIFIC XENOGENOUS ANTISERUM TO CELLS OF CHRONIC MYELOID-LEUKEMIA (CML) IN BLASTIC CRISIS
    BARYSHNIKOV, AJ
    RADZIKHOVSKAYA, RM
    MOROZOVA, LF
    BELYANCHIKOVA, NI
    SLAVINA, EG
    VINOGRADOVA, JE
    MKHEIDZE, DM
    POLOTSKAYA, TM
    VOLKOVA, MA
    SVETMOLDAVSKY, GJ
    NIKITIN, VD
    KUTIMOV, VA
    TRUBITSINA, VI
    GOLETSKY, SA
    GLAZUNOV, A
    BIOMEDICINE EXPRESS, 1976, 25 (09): : 316 - 317
12345